3 pathogenese und klinische symptome bei kindern und jugendlichen
3 pathogenese und klinische symptome bei kindern und jugendlichen
3 pathogenese und klinische symptome bei kindern und jugendlichen
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
Pathogenese <strong>und</strong> <strong>klinische</strong> Symptome <strong>bei</strong> Kindern <strong>und</strong> Jugendlichen, M. Knuf Seite 11<br />
3.6 Literatur<br />
1. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de<br />
Vijver D, Boucher CA, Koopmans MM, Rimmelzwaan GF, Kuiken T, Osterhaus AD,<br />
Fouchier RA (2009) Pathogenesis and transmission of swine origin 2009 A(H1N1) influenza<br />
in ferrets. Science 325:481–483<br />
2. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M (2001) The<br />
Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med<br />
344(12):889–896<br />
3. Haas W, Köpke K, Schweiger B, Buda S, Buchholz U, Harder T, Krause G (2009) Deutsch<br />
Arztebl 106:A1<br />
4. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K (2003) Systematic review<br />
and economic decision modelling for the prevention and treatment of influenza A and B.<br />
Health Technol Assess 7(35):iii–iv, xi–xiii, 1–170<br />
5. Principi N, Esposito S, Marchisio P, Gasparini R, Crovari P (2003) Socioeconomic impact of<br />
influenza on healthy children and their families. Pediatr Infect Dis J 22 [Suppl10]:207–210<br />
6. Forster J (2003) Influenza in children: the German perspective. Pediatr Infect Dis J 22<br />
[Suppl 10]: 215–217<br />
7. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg ME, Glover MJ, Likos AM, Posey DL,<br />
Klimov A, Lindstrom SE, Balish A, Medina MJ, Wallis TR, Guarner J, Paddock CD, Shieh<br />
WJ, Zaki SR, Sejvar JJ, Shay DK, Harper SA, Cox NJ, Fukuda K, Uyeki TM (2005)<br />
Influenza-associated deaths among children in the United States, 2003–2004. N Engl J Med<br />
353(24):2559–2567<br />
8. Monto AS, Sullivan KM (1993) Acute respiratory illness in the community. Frequency of<br />
illness and the agents involved. Epidemiol Infect 110:145–160<br />
9. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde<br />
V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D,<br />
Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L (2009) Triple-reassortant<br />
swine influenza A (H1) in humans in the United States, 2005–2009. N Engl J Med<br />
360(25):2616–2625<br />
10. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19232<br />
11. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E,<br />
Longini IM (2009) The transmissibility and control of pandemic influenza A (H1N1) virus.<br />
Science, DOI 10.1126/science.1177373<br />
12. Hackett S, Hill L, Patel J, Ratnaraja N, Ifeyinwa A, Farooqi M, Nusgen U, Debenham P,<br />
Gandhi D, Makwana N, Smit E, Welch S (2009) Clinical characteristics of paediatric H1N1<br />
admissions in Birmingham, UK. Lancet 374:605<br />
13. Lister P, Reynolds F, Parslow R, Chan A, Cooper M, Plunkett A, Riphagen S, Peters M<br />
(2009) Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in<br />
children. Lancet 374:605–607<br />
14. Centers for Disease Control and Prevention (CDC) (2009) Neurologic complications<br />
associated with novel influenza A (H1N1) virus infection in children – Dallas. MMWR Morb<br />
Mortal Wkly Rep 58(28):773–778<br />
15. Koliou M, Soteriades ES, Toumasi MM, Demosthenous A, Hadjidemetriou A (2009)<br />
Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the<br />
first 45 cases in Cyprus, June – August 2009. Euro Surveill 14(33)<br />
16. National Center for Immunization and Respiratory Diseases, Centers for Disease Control<br />
and Prevention (2009) Use of influenza A (H1N1) 2009 monovalent vaccine:<br />
recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.<br />
MMWR Recomm Rep 58(RR-10):1–8<br />
17. http://www.cdc.gov/vaccines/recs/ACIP/downloads/mtg-slides-jul09-flu/02-Flu-Fiore.pdf<br />
18. HPA Weekly National Influenza Report 06 August 2009;<br />
http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1249543005132)<br />
19. European Centre for Disease Prevention and Control (2009) Pandemic (H1N1) 2009 –<br />
Weekly report: individual case reports EU/EEA countries. 31 July 2009:<br />
http://ecdc.europa.eu/en/healthtopics/Documents/090731_Influenza_A(H1N1)_Analysis_of_<br />
individual_data_EU_EEA-EFTA.pdf<br />
20. Vaillant L, La Ruche G, Tarantola A, Barboza P, for the epidemic intelligence team at InVS<br />
(2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro<br />
Surveill 14(33)<br />
21. http://www.cdc.gov/vaccines/recs/ACIP/downloads/mtg-slides-jul09-flu/02-Flu-Fiore.pdf;<br />
http://www.phac-aspc.gc.ca/fluwatch/08-09/w32_09/index-eng.php,<br />
http://www.mja.com.au/public/rop/contents_rop.html<br />
Besonders wichtige Ar<strong>bei</strong>ten sind im Text <strong>und</strong> im Literaturverzeichnis fett gedruckt.